Prosecution Insights
Last updated: October 02, 2026
Application No. 18/567,872

HEXAGONAL BORON NITRIDE POWDER AND METHOD FOR PRODUCING SAME, AND COSMETICS AND METHOD FOR MANUFACTURING SAME

Non-Final OA §102§103
Filed
Dec 07, 2023
Priority
Jun 16, 2021 — nonprovisional of PCTJP2021022907
Examiner
WERTZ, ASHLEE ELIZABETH
Art Unit
1612
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Denka Company Limited
OA Round
3 (Non-Final)
53%
Grant Probability
Moderate
3-4
OA Rounds
6m
Est. Remaining
95%
With Interview

Examiner Intelligence

Grants 53% of resolved cases
53%
Career Allowance Rate
27 granted / 51 resolved
-7.1% vs TC avg
Strong +42% interview lift
Without
With
+42.1%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
57 currently pending
Career history
107
Total Applications
across all art units

Statute-Specific Performance

§101
0.5%
-39.5% vs TC avg
§103
48.4%
+8.4% vs TC avg
§102
6.7%
-33.3% vs TC avg
§112
15.9%
-24.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 51 resolved cases

Office Action

§102 §103
DETAILED ACTION Continued Examination A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 08/05/2026 has been entered. Previous Rejections Applicants' arguments, filed 08/05/2026, have been fully considered. Rejections and/or objections not reiterated from previous office actions are hereby withdrawn. The following rejections and/or objections are either reiterated or newly applied. They constitute the complete set presently being applied to the instant application. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1, 4 and 7 are rejected under 35 U.S.C. 102 as being as being anticipated by Tanimoto et al. (ACS Appl. Mater. Interfaces 2013, 5, 4374−4382). Claim 1 is anticipated because Tanimoto discloses aggregated hexagonal boron nitride (hBN) powder in Table 1 (pg. 4376) where example A(12.0) is disclosed to have a D10 of 4.3 µm, a D50 of 12.0 µm, and a D90 of 27.0 µm, wherein the values refer to the diameter of the secondary (aggregate) particles which are formed from hBN “primary particles” (pg. 4376). The D90/D10 ratio is 6.28, the D90/D50 ratio is 2.25, and the D50/D10 ratio is 2.79. If the prior art discloses a point within the claimed range, the prior art anticipates the claim. See MPEP 2131.03. Regarding the limitation of “volume-based particle sizes measured through a laser diffraction/light scattering method”, a chemical composition and its properties are inseparable. MPEP 2112.01 II. Therefore, because the prior art teaches hexagonal boron nitride aggregate particles with the same sizes (i.e., D10, D50, and D90 values), the properties the applicant discloses and/or claims (these volume-based particle sizes when measured through a laser diffraction/light scattering method) are reasonably expected to be necessarily present. Regarding claims 4 and 7, the limitations of “for a raw material for a cosmetic preparation” and “a cosmetic preparation” are an intended use of the particles. As these terms do not provide structural limitations and merely state the purpose or the intended use of the invention, they do not carry patentable weight. The claimed “hexagonal boron nitride powder according to claim 1” is anticipated by Tanimoto (Example A(12.0) in Table 1) and therefore, claims 4 and 7 are also anticipated. Response to Arguments Applicant' s arguments with respect to claim(s) 1, 4, and 7 have been considered but are moot because the new ground of rejection (Tanimoto) does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 4 and 7 are rejected under 35 U.S.C. 103 as being as being obvious over Tanimoto et al. (ACS Appl. Mater. Interfaces 2013, 5, 4374−4382) in view of Nakagawa et al. (US 2021/0253425 A1). Claim 1 is anticipated by Tanimoto, as discussed above. Regarding claims 4 and 7, Tanimoto is believed to be anticipatory as described above, but in the interest of completeness of prosecution, purely arguendo, and for the purposes of this ground of rejection only, Tanimoto will be interpreted as if it is not anticipatory. In that case, Tanimoto could be construed as not clearly and unequivocally disclosing the claimed invention because Tanimoto does not disclose that the particles are “for a raw material for a cosmetic preparation”, as recited in claim 4, or that the powder is “a cosmetic preparation”, as recited in claim 7. Nakagawa discloses a hexagonal boron nitride powder for cosmetic use [abstract] [0020]. Nakagawa teaches that hexagonal boron nitride powder has extremely excellent lubricity [0002] and that since hexagonal boron nitride is chemically stable and does not adversely affect the human body, it is widely used as a lubricant in cosmetics [0002] [0003] [0020]. Since Tanimoto generally teaches hexagonal boron nitride particles, it would have been prima facie obvious to one of ordinary skill in the art to include the particles within a cosmetic preparation because Nakagawa teaches the use of hexagonal boron nitride particles for cosmetic applications [abstract] [0020]. The ordinarily skilled artisan would have been motivated to include the particles in a cosmetic preparation because Nakagawa teaches that hexagonal boron nitride powder has extremely excellent lubricity [0002] and that since hexagonal boron nitride is chemically stable and does not adversely affect the human body, it is widely used as a lubricant in cosmetics [0002] [0003] [0020]. Response to Arguments Applicant' s arguments with respect to claim(s) 4 and 7 have been considered but are moot because the new ground of rejection (Tanimoto in view of Nakagawa) does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Ashlee E Wertz whose telephone number is (571)270-7663. The examiner can normally be reached Monday - Friday, 8 AM - 5 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Sahana Kaup can be reached at 571-272-6897. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ASHLEE E WERTZ/Examiner, Art Unit 1612
Read full office action

Prosecution Timeline

Show 2 earlier events
Apr 13, 2026
Response Filed
May 06, 2026
Final Rejection mailed — §102, §103
Jun 18, 2026
Response after Non-Final Action
Jul 29, 2026
Applicant Interview (Telephonic)
Jul 29, 2026
Examiner Interview Summary
Aug 05, 2026
Request for Continued Examination
Aug 06, 2026
Response after Non-Final Action
Sep 24, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12708618
PHARMACEUTICAL COMPOSITE FORMULATION COMPRISING PROTON PUMP INHIBITOR AND ANTACID, AND METHOD FOR PREPARING SAME
3y 7m to grant Granted Aug 18, 2026
Patent 12702632
PROTEASE FORMULATION FOR TREATMENT OF MICROBIAL INFECTIONS
3y 9m to grant Granted Aug 11, 2026
Patent 12673015
LOW SULFATE SURFACTANT COMPOSITION
3y 11m to grant Granted Jul 07, 2026
Patent 12660823
FUNGICIDAL COMBINATIONS
3y 6m to grant Granted Jun 23, 2026
Patent 12642797
COATED GRANULE, SOLID DISPERSION, AND PREPARATION CONTAINING VORTIOXETINE HYDROBROMIDE FOR ORAL TASTE MASKING
4y 5m to grant Granted Jun 02, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
53%
Grant Probability
95%
With Interview (+42.1%)
3y 4m (~6m remaining)
Median Time to Grant
High
PTA Risk
Based on 51 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month